NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Synergie Medication Collective

Synergie Medication Collective

Private
United StatesHealthcare & Life Scienceshttps://www.synergiecollective.com/

Last Round

Corporate Funding

Jan 5, 2023

Company Overview

Synergie Medication Collective is a healthcare company that operates a medication contracting organization focused on improving affordability and access to medical benefit drugs.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

medication contracting organizationMCOpharmacy benefit managementPBMmedication therapy managementMTMvalue-based contractingrebate managementprescription fulfillmentpatient care coordinationpharma rebate aggregatorgroup purchasing organizationGPOmedication adherencepayer-manufacturer negotiation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synergie Medication Collective Comparables

Compare Synergie Medication Collective with similar companies based on industry and business-model similarity.

Synergie Medication Collective comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CVS Health
70%
Prime Therapeutics
70%
Evio Pharmacy Solutions
69%

Synergie Medication Collective Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingJan 5, 2023

Key People

Founding team and executive leadership

Charlie J.

Interim Chief Executive Officer, General Counsel

Executive Team

Jarrod Henshaw

Chief Executive Officer

Executive Team

Sue Sommer

COO

Executive Team

Synergie Medication Collective Investors

Notable investors and investment history

Synergie Medication Collective investors
InvestorRounds
Blue Cross Blue Shield AssociationCorporate Funding
HMSACorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 12, 2024

    Grew 29% QoQ, from 21 to 27 employees.

Synergie Medication Collective Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synergie Medication Collective Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synergie Medication Collective's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited States
Employee Range47
Year Founded2023
Last FundingJan 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.